Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Candesartan and hydrochlorothiazide in isolated systolic hypertension

Date

Authors

Wing, Lindon M. H.

Arnolda, Leonard

Upton, Jane

Molloy, Danielle

Publisher

Carfax Publishing, Taylor & Francis Group

Abstract

Aim: We investigated the efficacy and safety of daily candesartan 8/16 mg and hydrochlorothiazide 12.5 mg as monotherapy and in combination in older patients with systolic hypertension. Methods: The study used a double-blind randomized placebo-controlled

Keywords

Keywords: antihypertensive agent; candesartan; hydrochlorothiazide; placebo; adult; aged; article; blood pressure regulation; clinical article; clinical trial; controlled clinical trial; controlled study; crossover procedure; diastolic blood pressure; dose response Blood pressure; Candesartan cilexetil; Elderly; Hydrochlorothiazide; Systolic hypertension

URI

http://hdl.handle.net/1885/23689

Collections

ANU Research Publications

Source

Blood Pressure

Type

Journal article

DOI

10.1080/08037050310014954